US Markets

Health Care Sector Update for 10/11/2019: ACRS, GERN, GILD, GLPG, JNJ, PFE, ABT, MRK, AMGN

Top Health Care Stocks:

JNJ: +1.41%

PFE: +1.12%

ABT: +0.35%

MRK: +0.41%

AMGN: +0.16%

Health care majors were trading higher pre-bell Friday.

Early movers include:

(+) Aclaris Therapeutics (ACRS), which was surging nearly 23% after saying it was selling the rights to its Rhofade 1% oxymetazoline hydrochloride topical cream and related intellectual property to privately-held dermatology firm EPI Health for up to $55 million in upfront and future cash payments.

(+) Geron (GERN) said the first patient has been dosed in the IMerge phase 3 trial to evaluate imetelstat as a potential alternative for patients with lower risk myelodysplastic syndromes (MDS) -- blood disorders that develop because bone marrow cells do not mature into healthy blood cells. Geron was recently gaining more than 3%.

(+) Gilead Sciences (GILD) and Galapagos (GLPG) said 52-week data from two phase 3 trials of filgotinib for moderately-to-severely active rheumatoid arthritis are consistent with and support the efficacy, safety and tolerability profiles demonstrated in the week-12 and week-24 analyses. Both companies were higher in recent trading.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ACRS GERN GILD GLPG JNJ

Latest Markets Videos